US Patent 12121562 Antigenic Epstein Barr virus polypeptides
Patent 12121562 was granted and assigned to Sanofi on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+19 properties)
Article (+215 characters)
US Patent 12121562 Antigenic Epstein Barr virus polypeptides
Article
Patent abstract
This disclosure relates to antigenic EBV polypeptides and their use in eliciting antibodies against EBV. Also disclosed are antigenic polypeptides comprising an EBV polypeptide and a ferritin protein.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chih-Jen Wei0
Gary J. Nabel0
Kurt Swanson0
Laura Nguyen0
Te-Hui Chou0
Date of Patent
October 22, 2024
0Patent Application Number
180679400
Date Filed
December 19, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12121562 Antigenic Epstein Barr virus polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
